Hiroichi Nagai

7.8k total citations · 2 hit papers
232 papers, 6.6k citations indexed

About

Hiroichi Nagai is a scholar working on Physiology, Immunology and Allergy and Immunology. According to data from OpenAlex, Hiroichi Nagai has authored 232 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Physiology, 79 papers in Immunology and Allergy and 75 papers in Immunology. Recurrent topics in Hiroichi Nagai's work include Asthma and respiratory diseases (92 papers), Allergic Rhinitis and Sensitization (56 papers) and Mast cells and histamine (52 papers). Hiroichi Nagai is often cited by papers focused on Asthma and respiratory diseases (92 papers), Allergic Rhinitis and Sensitization (56 papers) and Mast cells and histamine (52 papers). Hiroichi Nagai collaborates with scholars based in Japan, India and United States. Hiroichi Nagai's co-authors include Naoki Inagaki, Hiroyuki Tanaka, Akihide Koda, Shuh Narumiya, Masahiro Kimata, Toshiyuki Matsuoka, Toru Miura, Kōichi Nagao, Kazuhiko Arima and Shuji Toda and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Hiroichi Nagai

229 papers receiving 6.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prostaglandin D ₂ as a Mediator of Allergic Asthma

2000 625 citations Hiroichi Nagai et al. profile →
Periostin: A novel component of subepithelial fibrosis of bronchial asthma downstream of IL-4 and IL-13 signals

2006 530 citations Hiroichi Nagai et al. profile →

Peers

Hiroichi Nagai

PHYSI

IMMUN

MB

IA

PHARM

A. W. Ford‐Hutchinson Canada

Takehiko Yokomizo Japan

Bernhard A. Peskar Germany

Hyung‐Min Kim South Korea

Hyun‐Ja Jeong South Korea

D. A. Willoughby United Kingdom

Robert B. Zurier United States

Noriyasu Hirasawa Japan

Pierre Borgeat Canada

Xiu-Min Li United States

A. W. Ford‐Hutchinson Canada

Hiroichi Nagai

2.3k ×1.0

PHYSI

1.4k ×0.7

IMMUN

1.3k ×0.9

MB

633 ×0.5

IA

1.5k ×1.5

PHARM

Citations per year, relative to Hiroichi Nagai Hiroichi Nagai (= 1×) peers A. W. Ford‐Hutchinson

Countries citing papers authored by Hiroichi Nagai

Since Specialization

Citations

This map shows the geographic impact of Hiroichi Nagai's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroichi Nagai with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroichi Nagai more than expected).

Fields of papers citing papers by Hiroichi Nagai

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroichi Nagai. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroichi Nagai. The network helps show where Hiroichi Nagai may publish in the future.

Co-authorship network of co-authors of Hiroichi Nagai

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroichi Nagai. A scholar is included among the top collaborators of Hiroichi Nagai based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroichi Nagai. Hiroichi Nagai is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

1.

Adachi, Tetsuo, Hitomi Teramachi, Hirokazu Hara, et al.. (2009). Conduct of a PBL Tutorial on "Appropriate Use of Medicines" for First-grade Students and Analysis of Product Presentation Evaluations. Iryo Yakugaku (Japanese Journal of Pharmaceutical Health Care and Sciences). 35(3). 195–201. 5 indexed citations

2.

Tanaka, Hiroyuki, et al.. (2006). Immunopharmacological studies on the effects of Juzentaihoto and Hochuekkito on experimental autoimmune encephalomyelitis in rats. 23(6). 196–202. 2 indexed citations

3.

Oki, Toshihiko, Jiro Kitaura, Koji Eto, et al.. (2006). Integrin αIIbβ3 Induces the Adhesion and Activation of Mast Cells through Interaction with Fibrinogen. The Journal of Immunology. 176(1). 52–60. 35 indexed citations

4.

Maeda‐Yamamoto, Mari, Naoki Inagaki, Jiro Kitaura, et al.. (2004). O -Methylated Catechins from Tea Leaves Inhibit Multiple Protein Kinases in Mast Cells. The Journal of Immunology. 172(7). 4486–4492. 111 indexed citations

5.

Nagai, Hiroichi. (2004). Immunopharmacological studies on the anti-allergic actions of traditional Chinese medicines and related components. 21(5). 205–214. 4 indexed citations

6.

Liu, Baolin, Yoshihiro Inami, Hiroyuki Tanaka, et al.. (2002). P-53 Effects of Vaticanol (B, C and G), α-Viniferin and Hopeaphenol on the Release of Mediators from Bone Marrow-Derived Mast Cells. 19. 176. 1 indexed citations

7.

Wang, Ting, et al.. (2000). Effect of selective IL-6 inhibitor Am-80 on experimental autoimmune encephalomyelitis in DA rats.. PubMed. 21(11). 967–76. 7 indexed citations

8.

Inagaki, Naoki, et al.. (2000). Role of Cyclic 3'5'-Adenosine Monophosphate in the Regulation of Chemical Mediator Release and Cytokine Production from Cultured Human Mast Cells.. 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy. 49(49). 70.

9.

Nagai, Hiroichi, et al.. (2000). Effects of Sho-seiryu-to (Xiao-Qing-Long-Tang) on Experimental Allergic Reactions.. 17(2). 49–58. 5 indexed citations

10.

Nagai, Hiroichi, et al.. (1998). Effect of Byakko-ka-ninjin-to on Experimental Allergic Cutaneous Reaction.. 15(4). 208–215. 1 indexed citations

11.

Nagai, Hiroichi, et al.. (1998). Cyclosporin A and FK-506 Inhibit Development of Superantigen- Potentiated Collagen-Induced Arthritis in Mice. General Pharmacology The Vascular System. 30(5). 777–782. 5 indexed citations

12.

Inagaki, Naoki, et al.. (1997). Effect of Chinese herbal medicine, Sho-fu-san, on IgE antibody-mediated biphasic cutaneous reaction in mice.. 46. 71. 1 indexed citations

13.

Nagai, Hiroichi, et al.. (1996). An immunopharmacological study of the biphasic allergic skin reaction in mice.. 岐阜藥科大學紀要 = The annual proceedings of Gifu College of Pharmacy. 45(45). 90. 1 indexed citations

14.

Nagai, Hiroichi, Takanori Sengoku, Toru Miura, et al.. (1991). Anti-allergic action of gomisin A (TJN-101).. 40. 82. 1 indexed citations

15.

Tsuchiya, Hiroshi, et al.. (1985). Effect of saiboku-to, a blended Chinese traditional medicine, on Type I hypersensitivity reactions, particularly on experimentally-caused asthma.. Folia Pharmacologica Japonica. 85(1). 7–16. 17 indexed citations

16.

Koda, Akihide, et al.. (1982). . Folia Pharmacologica Japonica. 80(1). 31–41. 31 indexed citations

17.

Koda, Akihide, Hiroshi Mori, & Hiroichi Nagai. (1978). . Folia Pharmacologica Japonica. 74(4). 451–458. 5 indexed citations

18.

Mori, Hiroshi, Hiroichi Nagai, & Akihide Koda. (1978). Effect of α-mercaptopropionylglycine (α-MPG) and sodium dipropylacetate (DPA) on antibody formation (II) Immunosuppression induced by carcinostatic agents and glucocorticoid. Folia Pharmacologica Japonica. 74(6). 653–661. 8 indexed citations

19.

Koda, Akihide, Hiroichi Nagai, & Hiroshi Wada. (1970). Pharmacological actions of baicalin and baicalein. Folia Pharmacologica Japonica. 66(2). 194–213. 30 indexed citations

20.

Koda, Akihide, Hiroichi Nagai, & Hiroshi Wada. (1970). Pharmacological actions of baicalin and baicalein. Folia Pharmacologica Japonica. 66(2). 237–247. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact